ANVS·03615A108·US·equity·Healthcare - Biotechnology-13D/G
ANVS (ANNOVIS BIO INC) is held by 24 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($2.6M), TWO SIGMA INVESTMENTS, LP ($1.4M), RENAISSANCE TECHNOLOGIES LLC ($775,148). Net institutional sentiment: Mixed.
See how ANVS's score breaks down across 4 SEC sources
Showing 1-20 of 32
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer